My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Organovo Holdings (ONVO)
NASDAQ:ONVO
ONVO nasdaq
United States
Organovo Holdings

Organovo Holdings Stock Analysis & Ratings

Organovo Holdings Stock Analysis Overview

Smart Score
5
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Organovo Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

ONVO

ONVO Stock Stats

Previous Close$6.13
Open$6.1
Bid6.06 x 300
Ask6.92 x 1000
Today’s Range$6.06 - $6.2
52-Week Range$6.05 - $23.92
Volume41.19K
Average Volume66.69K
Market Cap$53.54M
Beta0.69
P/E Ratio-2.6
EPS-2.32
Earnings DateAug 08, 2019

Company Description

Organovo Holdings

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Sector
Healthcare
Industry
Medical Diagnostics & Research
CEO
Keith Murphy
Employees
9
ISIN
US68620A2033
Address
440 Stevens Avenue, Solana Beach, CA, 92075, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

ONVO FAQ

What was Organovo Holdings’s price range in the past 12 months?
Organovo Holdings lowest stock price was $6.05 and its highest was $23.92 in the past 12 months.
    What is Organovo Holdings’s market cap?
    Organovo Holdings’s market cap is $53.54M.
      What is Organovo Holdings’s price target?
      Currently, no data Available
      What do analysts say about Organovo Holdings?
      Not enough analysts have published a price target to provide an average price target.
      When is Organovo Holdings’s upcoming earnings report date?
      Organovo Holdings’s upcoming earnings report date is Aug 08, 2019 which is 2 years ago.
        How were Organovo Holdings’s earnings last quarter?
        Organovo Holdings released its earnings results on May 22, 2019. The company reported -$22.951 earnings per share for the quarter, missing the consensus estimate of -$1.133 by -$21.818.
          Is Organovo Holdings overvalued?
          According to Wall Street analysts Organovo Holdings’s price is currently Overvalued.
            Does Organovo Holdings pay dividends?
            Organovo Holdings does not currently pay dividends.
            What is Organovo Holdings’s EPS estimate?
            Organovo Holdings’s EPS estimate is -$1.
              How many shares outstanding does Organovo Holdings have?
              Organovo Holdings has 8,710,000 shares outstanding.
                What happened to Organovo Holdings’s price movement after its last earnings report?
                Organovo Holdings reported an EPS of -$22.951 in its last earnings report, missing expectations of -$1.133. Following the earnings report the stock price went down -4.386%.
                  Which hedge fund is a major shareholder of Organovo Holdings?
                  Among the largest hedge funds holding Organovo Holdings’s share is ARK Investment Management LLC. It holds Organovo Holdings’s shares valued at 4M.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis